Literature DB >> 29808315

[Treatment recommendations for protracted hip immaturity in infants : Conservative approach versus open reduction].

J Matussek1, E Dingeldey2.   

Abstract

The healthy upright posture is a result of a continuous maturation process of the locomotor system throughout skeletal growth rendering muscle strength and stability: The hip joint in its central position plays a key role for unimpaired and pain-free gait. Nonetheless, it is also regularly affected by delayed maturation, thus being of special interest for the disease screening procedures of every newborn child. Structured screening examinations in the first 3 postnatal months will ideally detect any dysplasia, therefore simple conservative interventions will usually accelerate the maturation process. Effective hip screening programs in Austria and Germany have reduced the necessity for open surgical hip reductions to a worldwide all-time low. Perinatal risk factor awareness in doctors and parents triggers an increased sensitivity to possible immature hip structures. Nevertheless, severe hip dysplasia in toddlers is regularly presented in pediatric orthopedic centers with or without hip dislocation, mostly due to the delay of or inefficiency of treatment options. This review deals with highly effective strategies for quick treatment and provides a balanced view on conservative and surgical methods.

Entities:  

Keywords:  Hip dysplasia; Newborn hip luxation; Open hip reduction; Pediatric orthopedics; Treatment algorithm

Mesh:

Year:  2018        PMID: 29808315     DOI: 10.1007/s00132-018-3579-7

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  22 in total

Review 1.  Ultrasonographic screening for developmental dysplasia of the hip: an epidemiologic analysis (Part I).

Authors:  M S Kocher
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2000-12

Review 2.  Preventive health care, 2001 update: screening and management of developmental dysplasia of the hip in newborns.

Authors:  H Patel
Journal:  CMAJ       Date:  2001-06-12       Impact factor: 8.262

3.  The functional method of treatment using a harness with stirrups as the primary method of conservative therapy for infants with congenital dislocation of the hip. 1957.

Authors:  A Pavlik
Journal:  Clin Orthop Relat Res       Date:  1992-08       Impact factor: 4.176

4.  Ultrasound screening of hips at risk for CDH. Failure to reduce the incidence of late cases.

Authors:  N M Clarke; J Clegg; A N Al-Chalabi
Journal:  J Bone Joint Surg Br       Date:  1989-01

5.  The diagnosis and management of neonatal hip instability: results of a clinical and targeted ultrasound screening program.

Authors:  Andrew G S Vane; David P Gwynne Jones; John D Dunbar; Jean-Claude Theis
Journal:  J Pediatr Orthop       Date:  2005 May-Jun       Impact factor: 2.324

Review 6.  Is Age or Surgical Approach Associated With Osteonecrosis in Patients With Developmental Dysplasia of the Hip? A Meta-analysis.

Authors:  Eduardo N Novais; Mary K Hill; Patrick M Carry; Patricia C Heyn
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

7.  Indicators of successful use of the Pavlik harness in infants with developmental dysplasia of the hip.

Authors:  H Atalar; U Sayli; O Y Yavuz; I Uraş; H Dogruel
Journal:  Int Orthop       Date:  2006-04-07       Impact factor: 3.075

8.  Effect of ultrasound screening on the rate of first operative procedures for developmental hip dysplasia in Germany.

Authors:  Rüdiger von Kries; Nicola Ihme; Doris Oberle; Anette Lorani; Renee Stark; Lutz Altenhofen; Fritz Uwe Niethard
Journal:  Lancet       Date:  2003-12-06       Impact factor: 79.321

9.  Universal or selective screening of the neonatal hip using ultrasound? A prospective, randomised trial of 15,529 newborn infants.

Authors:  K J Holen; A Tegnander; T Bredland; O J Johansen; O D Saether; S H Eik-Nes; T Terjesen
Journal:  J Bone Joint Surg Br       Date:  2002-08

10.  Open reduction for developmental dysplasia of the hip: failures of screening or failures of treatment?

Authors:  A P Sanghrajka; C F Murnaghan; A Shekkeris; D M Eastwood
Journal:  Ann R Coll Surg Engl       Date:  2013-03       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.